Specific fields

pelyon-expertise-assistance-conseil

Epidemiological studies

Epidemiological data summaries

Implementation of descriptive and analytical epidemiological studies according to ENCePP guidelines

undraw_charts_jj6t

Pharmacoepidemiology

Treatment patterns

Correct drug use evaluation

Comparative effectiveness research

pelyon-expertise-evaluations

Assessment

Health programs and actions

Health policies

pelyon-expertise-etude-economique

Economic studies

Cost of illness studies

Evaluation of healthcare consumption

pelyon-expertise-assistance-conseil

Methodological assistance and advice

Expert consulting on the design and implementation of observational studies and the identification of appropriate data sources

pelyon-expertise-image-outils
Our tools

Our studies are carried out using several databases from the Health Data Hub

Health insurance reimbursement database

SNDS: database covering over 98% of the population with health insurance in France, or around 65 million patients including primary and secondary care data

ESND: sample of 2% of the SNDS database

Individual linkage with field studies, Electronic health records (EHR) and data from registries.

REALLI: Sancare and PELyon are joining forces to offer a comprehensive solution for real-world study projects. Sancare’s Realli platform, which leverages machine learning to extract data from electronic medical records, combined with PELyon’s expertise in epidemiological studies, enables robust analysis and publication of research findings.

Confidentiality and independence

Studies carried out by PELyon are conducted in compliance with articles L. 1460-1 et seq. and R. 1461-1 et seq. of the French Public Health Code.

In this respect, PELyon has made a commitment to the Commission nationale de l’informatique et des libertés [French data protection authority] to comply with the frame of reference establishing the confidentiality, expertise and independence criteria for research laboratories and research departments as set out by the decree of 17th July 2017. This compliance undertaking demonstrates the commitment made by PELyon, and its employees, to comply with a number of confidentiality, security and independence measures in the context of its processing of personal data

PELyon also complies with the security frame of reference applicable to the National Health Data System resulting from the decree of 06th May 2024.

Quality

PELyon has set up a quality management system, certified ISO 9001 since 02 August 2022, compliant with the best practices applicable to the field of our activities (ENCEEP, ISPE, HAS) and with the regulations related to the protection of personal data (RGPD and “Loi informatique et Libertés”).

01

Study on adherence to asthma treatments

02

Initiation of anti-osteoporotic treatment and healthcare consumption

03

Early adherence to anti-glaucoma therapy

04

Assessment of the safety of long-acting beta-2-agonists in routine asthma care

05

Management and costs of rheumatoid arthritis

06

Frequency of comorbidities in COPD and impact on mortality

07

Management and healthcare consumption of patients with an NSCLC cancer or metastatic melanoma

08

Epidemiology and management of bone metastases